summary
Introduced
02/16/2023
02/16/2023
In Committee
02/22/2024
02/22/2024
Crossed Over
Passed
Dead
12/31/2024
12/31/2024
Introduced Session
193rd General Court
Bill Summary
For legislation to reduce health insurance co-pays for people with chronic conditions. Financial Services.
AI Summary
This bill aims to reduce health insurance co-pays for people with chronic conditions. It establishes a drug access program to enhance access to certain high-value generic and brand-name drugs used to treat diabetes, asthma, and heart conditions. The program identifies one generic and one brand-name drug per condition, and requires health plans to provide coverage for these drugs with no cost-sharing for the generic drugs and a $25 maximum co-pay per 30-day supply for the brand-name drugs. The bill also imposes limits on insulin co-pays, capping them at $25 per 30-day supply regardless of the amount or type of insulin needed.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (20)
Christine Barber (D)*,
William Driscoll Jr. (D)*,
Jenny Armini (D),
Mike Connolly (D),
Mindy Domb (D),
Pat Duffy (D),
Jamie Eldridge (D),
Colleen Garry (D),
Carmine Gentile (D),
Natalie Higgins (D),
Vanna Howard (D),
Adrian Madaro (D),
Sam Montaño (D),
Brian Murray (D),
Patrick O'Connor (R),
Lindsay Sabadosa (D),
Jon Santiago (D),
Tommy Vitolo (D),
Susannah Whipps (I),
Bud Williams (D),
Last Action
Accompanied a study order, see H4634 (on 05/09/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/193/H943 |
| BillText | https://malegislature.gov/Bills/193/H943.pdf |
Loading...